278 related articles for article (PubMed ID: 27760684)
21. The impact of self-selection based on HIV risk on the cost-effectiveness of preexposure prophylaxis in South Africa.
Jamieson L; Gomez GB; Rebe K; Brown B; Subedar H; Jenkins S; Shoko N; Bekker LG; Johnson LF; Meyer-Rath G
AIDS; 2020 May; 34(6):883-891. PubMed ID: 32004205
[TBL] [Abstract][Full Text] [Related]
22. Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020.
Tanner MR; Miele P; Carter W; Valentine SS; Dunville R; Kapogiannis BG; Smith DK
MMWR Recomm Rep; 2020 Apr; 69(3):1-12. PubMed ID: 32324724
[TBL] [Abstract][Full Text] [Related]
23. Adolescent Human Immunodeficiency Virus Care Providers' Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in Youth.
Mullins TL; Zimet G; Lally M; Kahn JA
AIDS Patient Care STDS; 2016 Jul; 30(7):339-48. PubMed ID: 27410497
[TBL] [Abstract][Full Text] [Related]
24. Towards a fair consideration of PrEP as part of combination HIV prevention in Latin America.
Ravasi G; Grinsztejn B; Baruch R; Guanira JV; Luque R; Cáceres CF; Ghidinelli M
J Int AIDS Soc; 2016; 19(7(Suppl 6)):21113. PubMed ID: 27760687
[TBL] [Abstract][Full Text] [Related]
25. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
Haribhai S; Khadka N; Mvududu R; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
[TBL] [Abstract][Full Text] [Related]
26. Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study.
van Vliet MM; Hendrickson C; Nichols BE; Boucher CA; Peters RP; van de Vijver DA
J Int AIDS Soc; 2019 Dec; 22(12):e25427. PubMed ID: 31855323
[TBL] [Abstract][Full Text] [Related]
27. Applying the HIV Prevention Cascade to an Evaluation of a Large-Scale Combination HIV Prevention Programme for Adolescent Girls and Young Women in South Africa.
Bergh K; Toska E; Duby Z; Govindasamy D; Mathews C; Reddy T; Jonas K
AIDS Behav; 2024 Apr; 28(4):1137-1151. PubMed ID: 37462890
[TBL] [Abstract][Full Text] [Related]
28. Integrated provision of topical pre-exposure prophylaxis in routine family planning services in South Africa: a non-inferiority randomized controlled trial.
Mansoor LE; Yende-Zuma N; Baxter C; Mngadi KT; Dawood H; Gengiah TN; Samsunder N; Schwartz JL; Doncel GF; Abdool Karim Q
J Int AIDS Soc; 2019 Sep; 22(9):e25381. PubMed ID: 31507088
[TBL] [Abstract][Full Text] [Related]
29. "I'm doing this test so I can benefit from PrEP": exploring HIV testing barriers/facilitators and implementation of pre-exposure prophylaxis among South African adolescents.
Yoshioka E; Giovenco D; Kuo C; Underhill K; Hoare J; Operario D
Afr J AIDS Res; 2020 Jul; 19(2):101-108. PubMed ID: 32326813
[TBL] [Abstract][Full Text] [Related]
30. A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South Africa, Uganda and Zimbabwe.
Dietrich JJ; Ahmed N; Tshabalala G; Wu M; Mulaudzi M; Hornschuh S; Atujuna M; Muhumuza R; Ssemata AS; Stranix-Chibanda L; Nematadzira T; Bekker LG; Martinson N; Seeley J; Fox J
PLoS One; 2023; 18(6):e0287627. PubMed ID: 37384792
[TBL] [Abstract][Full Text] [Related]
31. Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi.
Arnold T; Brinkley-Rubinstein L; Chan PA; Perez-Brumer A; Bologna ES; Beauchamps L; Johnson K; Mena L; Nunn A
PLoS One; 2017; 12(2):e0172354. PubMed ID: 28222118
[TBL] [Abstract][Full Text] [Related]
32. Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale-up: a synthesis of evidence from sub-Saharan Africa.
Eakle R; Weatherburn P; Bourne A
J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25306. PubMed ID: 31328429
[TBL] [Abstract][Full Text] [Related]
33. Initiation of HIV pre-exposure prophylaxis in adolescents and young adults: Barriers and opportunities.
Mocorro I; Sandhu PJ; Rowniak S; Leonard A
J Am Assoc Nurse Pract; 2020 Aug; 33(9):700-708. PubMed ID: 32804806
[TBL] [Abstract][Full Text] [Related]
34. Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection.
Walensky RP; Jacobsen MM; Bekker LG; Parker RA; Wood R; Resch SC; Horstman NK; Freedberg KA; Paltiel AD
J Infect Dis; 2016 May; 213(10):1523-31. PubMed ID: 26681778
[TBL] [Abstract][Full Text] [Related]
35. Pre-exposure prophylaxis for preventing acquisition of HIV: A cross-sectional study of patients, prescribers, uptake, and spending in the United States, 2015-2016.
Chan SS; Chappel AR; Maddox KEJ; Hoover KW; Huang YA; Zhu W; Cohen SM; Klein PW; De Lew N
PLoS Med; 2020 Apr; 17(4):e1003072. PubMed ID: 32275654
[TBL] [Abstract][Full Text] [Related]
36. Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provision.
Mudimu E; Peebles K; Mukandavire Z; Nightingale E; Sharma M; Medley GF; Klein DJ; Kripke K; Bershteyn A
PLoS One; 2020; 15(12):e0244761. PubMed ID: 33382803
[TBL] [Abstract][Full Text] [Related]
37. Assessing the acceptability of, adherence to and preference for a dual prevention pill (DPP) for HIV and pregnancy prevention compared to oral pre-exposure prophylaxis (PrEP) and oral contraception taken separately: protocols for two randomised, controlled, cross-over studies in South Africa and Zimbabwe.
Friedland BA; Mgodi NM; Palanee-Phillips T; Mathur S; Plagianos MG; Bruce IV; Lansiaux M; Murombedzi C; Musara P; Dandadzi A; Reddy K; Ndlovu N; Zulu SK; Shale LR; Zieman B; Haddad LB
BMJ Open; 2024 Mar; 14(3):e075381. PubMed ID: 38479746
[TBL] [Abstract][Full Text] [Related]
38. Implementation of pre-exposure prophylaxis for human immunodeficiency virus infection: progress and emerging issues in research and policy.
Cáceres CF; Borquez A; Klausner JD; Baggaley R; Beyrer C
J Int AIDS Soc; 2016; 19(7(Suppl 6)):21108. PubMed ID: 27760685
[TBL] [Abstract][Full Text] [Related]
39. From modeling to morals: imagining the future of HIV PREP in Lesotho.
Kenworthy NJ; Bulled N
Dev World Bioeth; 2013 Aug; 13(2):70-8. PubMed ID: 23800326
[TBL] [Abstract][Full Text] [Related]
40. Pre-exposure prophylaxis as an opportunity for engagement in HIV prevention among South African adolescents.
LoVette A; Kuo C; Giovenco D; Hoare J; Underhill K; Operario D
SAHARA J; 2022 Dec; 19(1):1-7. PubMed ID: 35135437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
